Induction of broad drug resistance in small cell lung cancer cells and its reversal by paclitaxel

International Journal of Cancer

Volumn 76, Issue 5, 1998, Pages 702-708

  Su, Gloria M I ^a   Davey, Mary W ^b   Davey, Ross A ^a  

^a ROYAL NORTH SHORE HOSPITAL   (Australia)

^b UNIVERSITY OF TECHNOLOGY SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORAMBUCIL; CISPLATIN; EPIRUBICIN; GLYCOPROTEIN P; PACLITAXEL;

ARTICLE; CANCER RESISTANCE; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; LUNG SMALL CELL CANCER; MULTIDRUG RESISTANCE; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; BACTERIAL PROTEINS; CARCINOMA, SMALL CELL; CHLORAMBUCIL; CISPLATIN; DRUG INTERACTIONS; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; DRUG SCREENING ASSAYS, ANTITUMOR; ETOPOSIDE; HUMANS; LUNG NEOPLASMS; P-GLYCOPROTEIN; PACLITAXEL; RNA, MESSENGER; SERINE ENDOPEPTIDASES; TUMOR CELLS, CULTURED; VINBLASTINE;

EID: 0031780225     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19980529)76:5<702::AID-IJC15>3.0.CO;2-5     Document Type: Article

References (30)

1. BARNOUIN, K., LEIER, I., JEDLITSCHKY, G., POURTIER MANZAANEDO, A., KONIG, J., LEHMANN, W.D. and KEPPLER, D., Multidrug resistance protein-mediated transport of chlorambucil and melphalan conjugated to glutathione. Brit. J. Cancer, 77, 201-209 (1998).
2. COLE, S.P., BMARDWAJ, G., GERLACH, J.H., MACKIE, J.E., GRANT, C.E., ALMQUIST, K.C., STEWART, A.J., KURZ, E.U., DUNCAN, A.M. and DEELEY, R.G., Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. Science, 258, 1650-1654 (1992).
3. DAVEY, M.W., HARGRAVE, R.M. and DAVEY, R.A. Comparison of drug accumulation in P-glycoprotein-expressing and MRP-expressing human leukaemia cells. Leukemia Res., 20, 657-664 (1996).
4. DAVEY, R.A., LONGHURST, T.J., DAVEY, M.W., BELOV, L., HARVIE, R.M., HANCOX, D. and WHEELER, H., Drug resistance mechanisms and MRP expression in response to epirubicin treatment in a human leukaemia cell line. Leukemia Res., 19, 275-282 (1995).
5. DAVEY, R.A., SU, G.M., HARGRAVE, R.M., HARVIE, R.M., BAGULEY, B.C. and DAVEY, M.W., Potential of circumvention of N-[2-(dimethylamino)ethyl]acridine-4-carboxamide (DACA), idarubicin and paclitaxel to circumvent three multidrug resistance phenotypes in vitro. Cancer Chemother Pharmacol., 39, 424-430 (1997).
6. FRIEDLANDER, M.L., BELL, D.R., LEARY, J. and DAVEY, R.A., Comparison of western blot analysis and immunocytochemical detection of P-glycoprotein in multidrug resistant cells. J. clin. Pathol., 42, 719-722 (1989).
7. GAZDAR, A.F., CARNEY, D.N., RUSSELL, E.K., SIMS, H.L., BAYLIN, S.B., BUNN, P.A. JR., GUCCION, J.G. and MINNA, J.D., Establishment of continuous, clonable cultures of small-cell carcinoma of the lung which have amine precursor uptake and decurhoxylation cell properties. Cancer Res., 40, 3502-3507 (1980).
8. HABER, M., NORRIS, M.D., KAVALLARIS, M., BELL, D.R., DAVBY, R.A., WHITE, L. and STEWART, B.W., Atypical multidrug resistance in a therapy-induced drug-resistant human leukemia cell line [LALW-2): resistance to Vinea alkaloids independent of P-glycoprotein. Cancer Res., 49, 5281-5287 (1989).
9. HARVIE, R.M., DAVEY, M.W. and DAVEY, R.A., Increased MRP expression is associated with resistance to radiation, anthracyclines and etoposide in cells treated with fractionated gamma-radiation. Int. J. Cancer. 73, 164-167 (1997).
10. HORWITZ., S.B., COHEN, D., RAO, S., RINGEL, I., SHEN, H.J. and YANG, C.P., Taxol: mechanisms of action and resistance. Monogr. nat. Cancer Inst., 15, 55-61 (1993).
11. ISHIKAWA, T., BAO, J.J., YAMANE, Y., AKIMARU, K., FRINDRICH, K., WRIGHT, C.D. and KUO, M.T., Coordinated induction of MRP/GS-X pump and gamma-glutamylcysteine synthetase by heavy metals in human leukemia cells. J. biol. Chem., 271, 14981-14988 (1996).
12. IZQUERDO, M.A., SHOEMAKER, R.H., FLENS, M.J., SCHEFFER, G.L., WU, L., PRATHER, T.R. and SCHEPER, R.J., Overlapping phenotypes of multidrug resistance among panels of human cancer-cell lines. Int. J. Cancer, 65, 230-237 (1996).
13. JAIN, N., LAM, Y.M., PYM, J. and CAMPLING, B.G., Mechanisms of resistance of human small cell lung cancer lines selected in VP-16 and cisplatin. Cancer, 77, 1797-1808 (1996).
14. JEKUNEN, A.P., CHRISTEN, R.D., SHALINSKY, D.R. and HOWELL, S.B., Synergistic interaction between cisplatin and taxol in human ovarian carcinoma cells in vitro. Brit. J. Cancer, 69, 299-306 (1994).
15. JENSEN, P.B., HOLM, B., SORENSEN, M., CHRISTENSEN, I.J. and SEHESTED, M., In vitro cross-resistance and collateral sensitivity in seven resistant small-cell lung cancer cell lines - preclinical identification of suitable drug partners to taxotere, taxol, topotccan and gemcitabin. Brit. J. Cancer, 75, 869-877 (1997).
16. KAVALLARIS, M., The role of multidrug resistance-associated protein (MRP) expression in multidrug resistance. Anti-Cancer Drugs, 8, 17-25 (1997).
17. KEPPLER, D. and KONIG, J. Expression and localization of the conjugate export pump encoded by the MRP2 (cMRP/cMOAT) gene in liver. FASEB J., 11, 509-516 (1997).
18. KOOL, M., DE HAAS, M., SCHEFFER, G.L., SCHEPER, R.J., VAN EIJK, M.J.T., JUIJN, J.A., BAAS, F. and BORST, P., Analysis of expression of cMOAT (MRP2), MRP3, MRP4, and MRP5, homologues of the multidrug resistance-associated protein gene (MRP1). in human cancer cell lines. Cancer Res., 57, 3537-3543 (1997).
19. LIEBMANN, J.E., FISHER, J., TEAGUE, D. and COOK, J.A., Sequence dependence of paclitaxel (taxol(r)) combined with cisplatin or alkylators in human cancer cells. Oncol. Res., 6, 25-31 (1994).
20. LITTLE, C., NAU, M., CARNEY, D., GAZDAR, A. and MINNA, J., Amplification and expression of the c-myc oncogene in human lung cancer cell lines. Nature (Lond.), 306, 194-196 (1983).
21. LONGHURST, T.J., O'NEILL, G.M., HARVIE, R.M. and DAVEY, R.A., The anthracycline resistance-associated (ara) gene, a novel gene associated with multidrug resistance in a human leukaemia cell line. Brit. J. Cancer, 74, 1331-1335 (1996).
22. MANZANO, R.G., VERSANVOORT, C., WRIGHT, K. and TWENTYMAN, P.R., Rapid recovery of a functional MDR phenotype caused by MRP after a transient exposure to MDR drugs in a revertant human lung cancer cell line. Europ. J. Cancer. 32A, 2136-2141 (1996).
23. MARKS, D.C., BELOV, L., DAVEY, M.W., DAVEY, R.A. and KIDMAN, A.D., The MTT cell viability assay for cytotoxicity testing in muiltidrug-resistant human leukemic cells. Leukemia Res., 16, 1165-1173 (1992).
24. MARKS, D.O. SU, G.M.I., DAVEY, R.A. and DAVEY, M.W., Extended-multidrug resistance in haematopoietic cells. Brit. J. Haematol., 95, 587-595 (1996).
25. MATTERN, J. and VOLM, M., Resistance mechanisms in human lung cancer. Invasion Metastasis, 15, 81-94 (1995).
26. MOTE, P.A., DAVEY, M.W., DAVEY, R.A. and OLIVER, L., Paclitaxel sensitizes multidrug resistant cells to radiation. Anticancer Drugs, 7, 182-188 (1996).
27. RIORDAN, J.R., DEUCHARS, K., KARTNER, N., ALON, N., TRENT, J. and LING, V., Amplification of P-glycoprotein genes in multidrug-resisiant mammalian cell lines. Nature (Lond.), 316, 817-819 (1985).
28. SU, G.M., DAVEY, M.W., DAVEY, R.A. and KIDMAN, A.D., Development of extended multidrug resistance in HL60 promyelocytic leukaemia cells. Brit. J. Haematol., 88, 566-574 (1994).
29. TANIGUCHI, K., WADA, M., KOHNO, K., NAKAMURA, T., KAWABE, T., KAWAKAMI, M., KAGOTANI, K., OKUMURA, K., AKIYAMA, S. and KUWANO, M., A human canalicular multispecific organic anion transporter (cMOAT) gene is overexpressed in cisplatin-resistant human cancer cell lines with decreased drug accumulation. Cancer Res., 56, 4124-4129 (1996).
30. VERSANTVOORT, C.H., WITHOFF, S., BROXTERMAN, H.J., KUIPER, C.M., SCHEPER, R.J., MULDER, N.H. and DE VRIES, E.G., Resistance-associated factors in human small-cell lung-carcinoma GLC4 sub-lines with increasing adriamycin resistance. Int. J. Cancer, 61, 375-380 (1995).